Nicholas Ashton
Tracked across 1 events · 28 articles · First seen Jul 07, 2026 · Last active Sep 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
The U.S. United States — Food and Drug Administration cleared the PrecivityAD2 blood test, developed by C2N Diagnostics, a startup founded by researchers at Washington University in St. Louis, to help evaluate Alzheimer's disease in…
Impact: Testing expert at Banner Health who cautioned that symptom-free people should not get Alzheimer's blood tests outside research studies.
Aug 21, 2026 · 28 articles
40
Nicholas Ashton warned against testingFDA Clears C2N Alzheimer Blood Test
ERGEN INTELLIGENCE
Track Nicholas Ashton live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard